GlassScriptPhysician profile
Nathaniel M Holte
NPI 1275276354
$4,359.00
in general payments reported to CMS, 2019-2025
10 companies · $2,544 in 2025
The $2,544 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $243 · 2023: $524 · 2024: $1,048 · 2025: $2,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,340 · Travel and Lodging: $1,024 · Education: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,339.82 |
| Travel and Lodging | $1,023.78 |
| Education | $752.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $946.97 | 2022-2025 | Actis |
| Arthrex, INC. | $842.92 | 2025 | |
| Elite Orthopedics, LLC | $826.09 | 2025 | |
| Stryker Corporation | $814.92 | 2023-2025 | Citrefix, 7 X 23mm Citrelock Implant, Infinity Adaptis |
| Depuy Synthes Sales INC. | $720.92 | 2023-2025 | Na, Motoband, Va-Lcp |
| Prism Medical | $70.50 | 2024-2025 | |
| Kerecis Limited | $42.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medline Industries LP | $42.45 | 2024 | |
| Restor3d, INC. | $29.84 | 2023 | |
| Pfizer INC. | $21.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Holte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.